MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 219 filers reported holding MERIDIAN BIOSCIENCE INC in Q4 2022. The put-call ratio across all filers is 4.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $4,683 | +17.1% | 141 | 0.0% | 0.00% | – |
| Q3 2022 | $4,000 | -100.0% | 141 | -100.0% | 0.00% | -100.0% |
| Q2 2022 | $108,449,000 | +14.2% | 3,565,063 | -2.5% | 0.72% | +28.5% |
| Q1 2022 | $94,934,000 | +25.0% | 3,656,943 | -1.8% | 0.56% | +28.3% |
| Q4 2021 | $75,976,000 | +1.2% | 3,724,310 | -4.6% | 0.44% | -4.6% |
| Q3 2021 | $75,104,000 | -12.9% | 3,903,560 | +0.5% | 0.46% | -9.3% |
| Q2 2021 | $86,186,000 | -24.4% | 3,885,748 | -10.5% | 0.51% | -25.7% |
| Q1 2021 | $113,973,000 | – | 4,341,834 | – | 0.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYQUANT CAPITAL SAS | 134,804 | $4,477 | 11.01% |
| Vazirani Asset Management LLC | 115,774 | $3,845 | 6.51% |
| FIFTH LANE CAPITAL, LP | 185,914 | $6,174,204 | 5.56% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1,939,075 | $64,396,681 | 5.01% |
| Crystalline Management Inc. | 244,453 | $8,118,284 | 4.08% |
| FNY Investment Advisers, LLC | 51,000 | $1,693 | 2.36% |
| HAVENS ADVISORS LLC | 26,800 | $890,028 | 2.26% |
| Euclidean Technologies Management, LLC | 62,995 | $2,092,064 | 1.99% |
| Sand Grove Capital Management LLP | 537,060 | $17,836 | 1.70% |
| Crabel Capital Management, LLC | 120,337 | $3,996 | 1.45% |